Biotricity Inc. (Biotricity) today announced its patent filing for the company’s Bioheart device. Bioheart, regarded as one of the most innovative wearable heart monitoring solutions and recognized as one of TIME Magazine’s Best Inventions of 2022 stands as a “game changer” in the industries of personal heart and remote lifestyle monitoring. This patent safeguards Bioheart’s exclusive 3-view dry-contact technology, advanced sensor system, unique design, and compact form factor, a combination that’s never been seen in the consumer market.

Biotricity Inc. (Biotricity) today announced the filing of a patent application for its groundbreaking Biotres device. This patent protects Biotres’ proprietary 3 channel technology, multiple sensors, architecture and compact form factor, a combination that has never been done before.  This filing expands the Company’s IP portfolio while increasing market barriers.

Biotricity Inc. (Biotricity)announced today the official launch a new digital presence that illustrates more completely the depth of Biotricity technologies and solutions.  The company has built a suite of solutions that combine connectivity, smart analytics, AI and cutting-edge cloud technologies. The solutions support individuals and patients from diagnostics to disease management depending on the solution utilized.